Holen Sie sich die Stockscreener-App
9.86
1.65%
0.16
Vorhandelsmarkt:
9.79
-0.07
-0.71%
Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten
How (TNXP) Movements Inform Risk Allocation Models - Stock Traders Daily
Why TNXP Stock Is Suddenly Back On Retail Radar - Stocktwits
Tonix Pharmaceuticals (NASDAQ:TNXP) Downgraded by Wall Street Zen to Sell - MarketBeat
Tonix Pharmaceuticals (TNXP) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
Tonix expands Medicare coverage for fibromyalgia drug TONMYA - Investing.com
Tonix expands Medicare coverage for fibromyalgia drug TONMYA By Investing.com - Investing.com Australia
Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA® - GlobeNewswire
Raymond James reiterates Strong Buy on Tonix Pharma stock at $27 - Investing.com Nigeria
TNXP Looks 2393.0% Overvalued on GF Value™ - GuruFocus
Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial Nears - marketbeat.com
Could Market Volatility Test Tonix Pharmaceuticals (NASDAQ:TNXP)? - Kalkine Media
Tonix Pharmaceuticals at Cantor conference: launch gains and pipeline push By Investing.com - Investing.com India
Q3 EPS Estimate for Tonix Pharmaceuticals Raised by Analyst - marketbeat.com
What macro factors could move Tonix Pharmaceuticals (NASDAQ:TNXP) shares this week? - Kalkine Media
Tonix Pharma Appoints New Chief Commercial Officer - The Globe and Mail
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Passes Above Two Hundred Day Moving AverageWhat's Next? - marketbeat.com
symbol__ Stock Quote Price and Forecast - CNN
Tonix Pharmaceuticals Promotes Thomas Englese to Chief Commercial Officer - Minichart
TNXP Looks 393.2% Overvalued on GF Value™ - GuruFocus
Tonix Pharmaceuticals Holding Corp. Announces Appointment of Thomas Englese to Chief Commercial Officer, Effective September 8, 2026 - marketscreener.com
Why is Tonix Pharmaceuticals (NASDAQ:TNXP) stock in focus as Wall Street reopens today? - Kalkine Media
Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer - Yahoo Finance
TNXP Slips After Hours On Slower Than Expected Launch For Fibromyalgia Drug - Stocktwits
Price-Driven Insight from (TNXP) for Rule-Based Strategy - Stock Traders Daily
TNXP Stock Dives For Four Straight Sessions — Retail Eyes Drug Pipeline Payoff - Stocktwits
TNXP|Tonix Pharmaceuticals Holding Corp|Price:13.140|Chg%:-0.230 - TradingKey
TNXP: $11.0 Million in Tonmya® Net Revenue in 2Q26 - Yahoo Finance
Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference - GlobeNewswire
Tonix Pharmaceuticals Holding Corp. (TNXP) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Tonix Pharmaceuticals CEO Seth Lederman buys $27,580 in stock By Investing.com - Investing.com South Africa
Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Buys $27,580.00 in Stock - MarketBeat
Tonix Pharmaceuticals CEO Seth Lederman buys $27,580 in stock - Investing.com
Tonix Pharma (NASDAQ: TNXP) CEO adds 2,000 shares in IRA - stocktitan.net
Tonix Pharmaceuticals Holding Corp. (TNXP) Peer Comparison – Compare with Others - Value Research
Tonix Pharmaceuticals (NASDAQ:TNXP) Rating Increased to Hold at Wall Street Zen - marketbeat.com
Tonix Pharmaceuticals Holding Corp. (TNXP) Key Financial Ratios – Valuation, Profitability & More - Value Research
Tonix (TNXP) Earnings Report: Profit Per Share Surpasses Its Benchmark in the Latest Reading - careplusvn.com
Tonix Pharmaceuticals director bagger buys $12,600 in stock By Investing.com - Investing.com Canada
Tonix Pharmaceuticals director bagger buys $12,600 in stock - Investing.com
Tonix (TNXP) Market: Adds 1.29% to Close at $12.55; the Near-Term Reference Band Stretches From $11.92 to $13.18 in the Latest ReadingFair Value Gap - careplusvn.com
Tonix (TNXP) Results Review: Profit Per Share Surpasses Its Benchmark for the Current Session; Post-Report: The Stock Records a 2.51% Decrease in Latest TradingEarnings Risk Report - careplusvn.com
Tonix Pharmaceuticals (TNXP) Q2 2026 Earnings Call Transcript - AOL.com
Tonix Pharma Names CEO Seth Lederman Interim CMO - The Globe and Mail
Tonix (TNXP) Daily Snapshot: Finishes 0.16% Higher at $12.68 in Latest Trading; the $12.05 to $13.31 Range Remains in Focus under the Current SnapshotValue Area High - Vinanet
Tonix Pharmaceuticals Highlights TONMYA Sales Surge, Lyme and Depression Pipeline - MarketBeat
Tonix Pharmaceuticals (TNXP) Holds Ground at $12.66 as Traders Eye $13.29 ResistanceTrend Reversal Picks - vinanet.vn
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):